Skip to main content
Brian Alexander, MD, Radiation Oncology, Boston, MA

BrianMichaelAlexanderMDMPH

Radiation Oncology Boston, MA

Central Nervous System Cancer

Assistant Professor, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School

Dr. Alexander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Alexander's full profile

Already have an account?

  • Office

    75 Francis St
    Boston, MA 02115
    Phone+1 617-732-7560

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2005 - 2010
  • St Joseph Mercy Ann Arbor
    St Joseph Mercy Ann ArborInternship, Transitional Year, 2004 - 2005
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2006 - 2026
  • MI State Medical License
    MI State Medical License 2004 - 2005
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Original Article Neurosurgical Resection and Stereotactic Radiation Versus Stereotactic Radiation Alone in Patients with a Single or Solitary Brain Metastasis  
    John G Phillips, Itai M Pashtan, Ayal A Aizer, Elizabeth B Claus, Shyam K Tanguturi, Daniel N Cagney, Brian M Alexander, Nayan Lamba, Alexandra J Golby, ScienceDirect

Press Mentions

  • A Novel Method for Biomarker Discovery in Clinical Trials
    A Novel Method for Biomarker Discovery in Clinical TrialsMay 1st, 2019
  • Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?
    Could a New Business Model Make Clinical Drug Trials More Accessible to Patients?March 8th, 2018
  • Abemaciclib, Neratinib Explored in Glioblastoma Trial
    Abemaciclib, Neratinib Explored in Glioblastoma TrialSeptember 6th, 2017
  • Join now to see all

Professional Memberships